Links

Tools

Export citation

Search in Google Scholar

Metabolic syndrome and dementia associated with Parkinson's disease: impact of age and hypertension

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

Objective: To determine correlations between age and metabolic disorders in Parkinson's disease (PD) patients. Methods: This observational cross-sectional study included brief tests for dementia and the Mattis test. Signals of metabolic syndrome were evaluated. Results: There was no significant effect from the presence of hypertension (OR=2.36 for patients under 65 years old and OR=0.64 for patients over 65), diabetes or hypercholesterolemia regarding occurrences of dementia associated with PD (24% of the patients). The study demonstrated that each year of age increased the estimated risk of dementia in PD patients by 9% (OR=1.09; 95%Cl: 1.01-1.17). Conclusion: There was no evidence to correlate the presence of metabolic syndrome with the risk of dementia that was associated with PD. The study confirmed that dementia in PD is age dependent and not related to disease duration. ; OBJETIVO: Determinar correlações entre idade e acometimento metabólico em doentes com Parkinson. MÉTODOS: Estudo observacional, transversal, incluindo testes breves para demência e teste de Mattis. Foi avaliada presença de síndrome metabólica. RESULTADOS: Não houve efeito significativo da presença de hipertensão arterial (OR=2,36 em pacientes com menos de 65 anos e OR=0,64 em maiores de 65 anos), diabetes e hipercolesterolemia sobre ocorrência de demência associada com a doença de Parkinson (24% dos pacientes). O estudo demonstrou que, a cada ano de idade, o risco estimado para presença de demência em parkinsonianos aumentou em 9% (OR=1,09; IC95%: 1.01-1.17). CONCLUSÃO: Não houve evidências para associar presença de síndrome metabólica com o risco de demência associada à doença de Parkinson. O estudo confirmou que a demência na doença de Parkinson é idade-dependente e não está relacionada ao tempo de duração da doença.